Literature DB >> 19387771

Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis.

Alessandra Bastian Francesconi1, Marco Matos, Joseph C Lee, David K Wyld, Andrew D Clouston, David Macfarlane.   

Abstract

In adults, nesidioblastosis is a very infrequent condition and a rare cause of symptomatic presentations. The diagnosis of nesidioblastosis may be difficult with functional and anatomical imaging modalities. "Slight focal" pancreatic abnormalities using (111)In-pentetreotide imaging has been reported in patients with hyperinsulinaemic hypoglycaemia, confirmed histologically as nesidioblastosis. We describe a 60-year-old man who presented with a 1-year history of intermittent faecal urgency and refractory diarrhoea, non-specific laboratory results, negative imaging results (CT, MRI and EUS), a FNA biopsy that was inconclusive, but suggested an endocrine cell neoplasm, and a (111)In-pentetreotide scan that showed a moderately intense focal uptake clearly localised to the pancreatic head on a low-dose fusion CT. The histopathology of the specimen confirmed the diagnosis of nesidioblastosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387771     DOI: 10.1007/s12149-009-0252-6

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  2 in total

1.  Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.

Authors:  Vikas Prasad; Aurora Sainz-Esteban; Ruza Arsenic; Ursula Plöckinger; Timm Denecke; Ulrich-Frank Pape; Andreas Pascher; Peter Kühnen; Marianne Pavel; Oliver Blankenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-29       Impact factor: 9.236

2.  Diffuse nesidioblastosis with hypoglycemia mimicking an insulinoma: a case report.

Authors:  Chiara Ferrario; Delphine Stoll; Ariane Boubaker; Maurice Matter; Pu Yan; Jardena J Puder
Journal:  J Med Case Rep       Date:  2012-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.